GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Net Change in Cash

Zelluna ASA (OSTO:ULTIO) Net Change in Cash : kr-159.19 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Zelluna ASA's Net Change in Cash for the three months ended in Dec. 2024 was kr-23.63 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was kr-159.19 Mil.


Zelluna ASA Net Change in Cash Historical Data

The historical data trend for Zelluna ASA's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA Net Change in Cash Chart

Zelluna ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.32 133.24 -148.86 -158.75 -159.19

Zelluna ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.71 -46.60 -49.56 -39.40 -23.63

Zelluna ASA Net Change in Cash Calculation

Zelluna ASA's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Zelluna ASA's Net Change in Cash for the quarter that ended in Dec. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-159.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zelluna ASA Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Zelluna ASA's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Zelluna ASA Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Zelluna ASA Headlines

No Headlines